Interim Platform Director: Dr. Peter McPherson

Founded in 2011, Clinical Proteomics is a joint venture between McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC), offering mass spectrometry support to all investigators, including affiliated hospitals, institutes and beyond.

The Clinical Proteomics Core specializes in discovery-based proteomics using state-of-the art instrumentation and streamlined bioinformatics coupled with extensive expertise. 

Services offered:

• advanced mass spectrometry and proteomics technologies for protein and lipid identification and quantitation, as well as affinity enrichment and MS identification of phosphopeptides
• peptide synthesis to be used for absolute quantification through single reaction monitoring (SRM) as well as for peptide antibody generation and purification
• advice and strategy for proteomics research
• experimental design and troubleshooting
• support for grant applications
• analysis, data interpretation, and training

Clinical Proteomics Core on iLab